Swiss Researchers Use New Mass Spectrometry Technique to Obtain Protein Data, Create Strategy That Could Lead to Clinical Laboratory Advances in Personalized Medicine

Researchers believe they have begun to crack open a ‘black box’ involving the genomes and diseases of individual patients Researchers in Switzerland are developing a new way to use mass spectrometry to explain why patients respond differently to specific therapies. The method potentially could become a useful tool for clinical laboratories that want to support the practice of precision medicine. It is also one more example of how mass spectrometry is being used by researchers to develop new...

Research Team at University of California Santa Barbara Achieves In Vivo Monitoring of Therapeutic Drugs with Technology That Pathologists Could Adapt for Clinical Diagnostic Purposes

Published study involved a demonstration of the MEDIC device’s ability to measure therapeutic drugs in animals, as well as human whole blood Researchers at the University of California Santa Barbara (UCSB) are making rapid progress in designing a biosensor that can measure therapeutic levels of a prescription drug in real time within the patient. This technology has interesting implications for anatomic pathology and clinical laboratory testing. The research team has developed a small...